{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:16Z","timestamp":1783575256529,"version":"3.55.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Graves\u2019 disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR). The autoimmune reaction does not only lead to overstimulation of the thyroid gland, but very often also to an immune reaction against antigens within the orbital tissue leading to thyroid eye disease, which is characterized by activation of orbital fibroblasts, orbital generation of adipocytes and myofibroblasts and increased hyaluronan production in the orbit. Thyroid eye disease is the most common extra-thyroidal manifestation of the autoimmune Graves\u2019 disease. Several studies indicate an important role of sphingolipids, in particular the acid sphingomyelinase\/ceramide system and sphingosine 1-phosphate in thyroid eye disease. Here, we discuss how the biophysical properties of sphingolipids contribute to cell signaling, in particular in the context of thyroid eye disease. We further review the role of the acid sphingomyelinase\/ceramide system in autoimmune diseases and its function in T lymphocytes to provide some novel hypotheses for the pathogenesis of thyroid eye disease and potentially allowing the development of novel treatments.<\/jats:p>","DOI":"10.3389\/fendo.2023.1170884","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:42:27Z","timestamp":1680586947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Sphingolipids in thyroid eye disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Anne","family":"Gulbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina-Eva","family":"G\u00f6rtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Gulbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000484621","article-title":"Blockade of experimental multiple sclerosis by inhibition of the acid sphingomyelinase\/ceramide system","volume":"25","author":"Becker","year":"2017","journal-title":"Neurosignals"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.33594\/000000183","article-title":"Pharmacological inhibition of acid sphingomyelinase ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Walter","year":"2019","journal-title":"Neurosignals"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000481968","article-title":"Regulation of arthritis severity by the acid sphingomyelinase","volume":"43","author":"Beckmann","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103109","article-title":"Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis","volume":"188","author":"Schiffmann","year":"2012","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.14.1.111","article-title":"Functions of lipid rafts in biological membranes","volume":"14","author":"Brown","year":"1998","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/1097-4652(200009)184:3<285::AID-JCP2>3.0.CO;2-3","article-title":"Compartmentalization of ceramide signaling: Physical foundations and biological effects","volume":"184","author":"Kolesnick","year":"2000","journal-title":"J Cell Physiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature07596","article-title":"Direct observation of the nanoscale dynamics of membrane lipids in a living cell","volume":"457","author":"Eggeling","year":"2009","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: Lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608445200","article-title":"A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligosaccharides and ceramides","volume":"282","author":"Ishibashi","year":"2007","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101207200","article-title":"CD95 signaling via ceramide-rich membrane rafts","volume":"276","author":"Grassm\u00e8","year":"2001","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207146","article-title":"Raft ceramide in molecular medicine","volume":"22","author":"Gulbins","year":"2003","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm823","article-title":"Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts","volume":"9","author":"Grassm\u00e8","year":"2003","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80448-1","article-title":"Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells","volume":"91","author":"Grassm\u00e8","year":"1997","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01851-2","article-title":"Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of neisseria gonorrhoeae","volume":"478","author":"Hauck","year":"2000","journal-title":"FEBS Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101866200","article-title":"Ceramide enables fas to cap and kill","volume":"276","author":"Cremesti","year":"2001","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5045","article-title":"Molecular mechanisms of ceramide-mediated CD95 clustering","volume":"284","author":"Grassm\u00e8","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4049\/jimmunol.168.1.298","article-title":"Ceramide-rich membrane rafts mediate CD40 clustering","volume":"168","author":"Grassm\u00e8","year":"2002","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209568","article-title":"TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis","volume":"25","author":"Dumitru","year":"2006","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm977","article-title":"PAF-mediated pulmonary edema: A new role for acid sphingomyelinase and ceramide","volume":"10","author":"G\u00f6ggel","year":"2004","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M500835200","article-title":"Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms","volume":"280","author":"Grassm\u00e8","year":"2005","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M414569200","article-title":"Caspase-dependent and -independent activation of acid sphingomyelinase signaling","volume":"280","author":"Rotolo","year":"2005","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nm1539","article-title":"Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide","volume":"13","author":"Lang","year":"2007","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.05.001","article-title":"\u03b21-integrin accumulates in cystic fibrosis luminal airway epithelial membranes and decreases sphingosine promoting bacterial infections","volume":"21","author":"Grassm\u00e9","year":"2017","journal-title":"Cell Host Microbes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3619","article-title":"Lipid raft redox signaling: Molecular mechanisms in health and disease","volume":"15","author":"Jin","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.139287","article-title":"Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function","volume":"285","author":"Perrotta","year":"2010","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201903176","article-title":"Fusion of lysosomes to plasma membrane initiates radiation-induced apoptosis","volume":"219","author":"Ferranti","year":"2020","journal-title":"J Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.19.5252","article-title":"Cathepsin d targeted by acid sphingomyelinase-derived ceramide","volume":"18","author":"Heinrich","year":"1999","journal-title":"EMBO J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1096\/fj.00-0370fje","article-title":"Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release","volume":"15","author":"Huwiler","year":"2001","journal-title":"FASEB J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0092-8674(00)80183-X","article-title":"Kinase suppressor of ras is ceramide-activated protein kinase","volume":"89","author":"Zhang","year":"1997","journal-title":"Cell"},{"key":"B33","first-page":"91","article-title":"Ceramide-activated protein phosphatase: Partial purification and relationship to protein phosphatase 2A","volume":"25","author":"Dobrowsky","year":"1993","journal-title":"Adv Lipid Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07188.x","article-title":"PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid","volume":"14","author":"Muller","year":"1995","journal-title":"EMBO J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1021\/bi981401i","article-title":"Selective ceramide binding to protein kinase c-alpha and -delta isoenzymes in renal mesangial cells","volume":"37","author":"Huwiler","year":"1998","journal-title":"Biochemistry"},{"key":"B36","article-title":"Ceramide generation is essential for enhancement of viral uptake in dendretic cells","volume":"5","author":"Avota","year":"2009","journal-title":"PloS Pathog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1059","article-title":"Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"8","author":"Sentelle","year":"2012","journal-title":"Nat Chem Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1194\/jlr.M300347-JLR200","article-title":"The structural requirements for ceramide activation of serine-threonine protein phosphatases","volume":"45","author":"Chalfant","year":"2004","journal-title":"J Lipid Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000623","article-title":"Induction of membrane ceramides: A novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression","volume":"5","author":"Gassert","year":"2009","journal-title":"PloS Pathog"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.34.20465","article-title":"Tyrosine phosphorylation-dependent suppression of a voltage-gated k+ channel in T lymphocytes upon fas stimulation","volume":"271","author":"Szabo","year":"1996","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.94.14.7661","article-title":"Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases","volume":"94","author":"Gulbins","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.13795","article-title":"Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids","volume":"96","author":"Lepple-Wienhues","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00763-0","article-title":"Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms","volume":"305","author":"Bock","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1210\/edrv.19.6.0352","article-title":"The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocrine Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of graves' ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"B47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: A 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220935","article-title":"Current insights into the pathogenesis of graves\u2019 orbitopathy","volume":"41","author":"Eckstein","year":"2009","journal-title":"Hormone Metab Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.3.667","article-title":"Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors","volume":"72","author":"Dumont","year":"1992","journal-title":"Physiol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of graves' ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02033.x","article-title":"Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant graves\u2019 disease differ and suggest ophthalmopathy is a multiantigenic disease","volume":"60","author":"Goh","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00740.x","article-title":"Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of l-thyroxine therapy","volume":"51","author":"Khoo","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02143.x","article-title":"Clinical results of anti-inflammatory therapy in graves' ophthalmopathy and association with thyroidal autoantibodies","volume":"61","author":"Eckstein","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1055\/a-1373-5523","article-title":"Predicting the relapse of hyperthyroidism in treated graves' disease with orbitopathy by serial measurements of TSH-receptor autoantibodies","volume":"53","author":"St\u00f6hr","year":"2021","journal-title":"Horm Metab Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00572.2011","article-title":"Expression of functional TSH receptor in white adipose tissues of Hyt\/Hyt mice induces lipolysis in vivo. am","volume":"302","author":"Endo","year":"2012","journal-title":"J Physiology: Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves' disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031427","article-title":"Evidence for enhanced adipogenesis in the orbits of patients with graves' ophthalmopathy","volume":"89","author":"Kumar","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/JME-11-0006","article-title":"A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with graves\u2019 ophthalmopathy","volume":"46","author":"Kumar","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1279","article-title":"Hypoxia-dependent HIF-1 activation impacts on tissue remodeling in graves' ophthalmopathy-implications for smoking","volume":"101","author":"G\u00f6rtz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"bqac203","DOI":"10.1210\/endocr\/bqac203","article-title":"Macrophage-orbital fibroblast interaction and hypoxia promote inflammation and adipogenesis in graves' orbitopathy","volume":"164","author":"G\u00f6rtz","year":"2022","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-r expression and cytokine profile in orbital tissue of active vs. inactive graves' ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol- (Oxf)."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1215568","article-title":"Thyroid autoimmunity and environment","volume":"41","author":"Tanda","year":"2009","journal-title":"Horm Metab Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","article-title":"Immunological aspects of graves' ophthalmopathy","volume":"2019","author":"\u0141acheta","year":"2019","journal-title":"Biomed Res Int"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.5603\/EP.2014.0021","article-title":"The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD)","volume":"65","author":"Miko\u015b","year":"2014","journal-title":"Endokrynol Pol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095937","article-title":"The immunology of fibrosis","volume":"31","author":"Wick","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nri2660","article-title":"Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective","volume":"9","author":"Weaver","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"dgaa124","DOI":"10.1210\/clinem\/dgaa124","article-title":"Evidence for associations between Th1\/Th17 \u201cHybrid\u201d phenotype and altered lipometabolism in very severe graves orbitopathy","volume":"105","author":"Fang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17863","article-title":"The role of sphingosine-1-phosphate in adipogenesis of graves' orbitopathy","volume":"57","author":"Kim","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/JME-21-0057","article-title":"Sphingosine-1-phosphate mediates fibrosis in orbital fibroblasts in graves' orbitopathy","volume":"66","author":"Ko","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-017-1037-3","article-title":"Sphingosine-1-phosphate is involved in inflammatory reactions in patients with graves\u2019 orbitopathy","volume":"66","author":"Seo","year":"2017","journal-title":"Inflammation Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02311-7","article-title":"Lessons from mouse models of graves' disease","volume":"68","author":"Eckstein","year":"2020","journal-title":"Endocrine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European group on graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.024","article-title":"Teprotumumab interpreting the clinical trials in the context of thyroid eye disease pathogenesis and current therapies","volume":"128","author":"Winn","year":"2021","journal-title":"Ophthalmology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1304","article-title":"Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female graves' orbitopathy mouse model","volume":"157","author":"G\u00f6rtz","year":"2016","journal-title":"Endocrinology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25466","article-title":"CD40 enhances sphingolipids in orbital fibroblasts: Potential role of sphingosine-1-phosphate in inflammatory T-cell migration in graves' orbitopathy","volume":"59","author":"Pl\u00f6hn","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03784-5","article-title":"The transmembranous domain of CD40 determines CD40 partitioning into lipid rafts","volume":"534","author":"Bock","year":"2002","journal-title":"FEBS-Lett"},{"key":"B80","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17863","article-title":"The role of sphingosine-1-phosphate in adipogenesis of graves\u2019 orbitopathy","volume":"57","author":"Kim","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20684","article-title":"Sphingosine-1-phosphate mediates fibrosis in orbital fibroblasts in graves\u2019 orbitopathy","volume":"58","author":"Ko","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303022200","article-title":"Activation of human acid sphingomyelinase through modification or deletion of c-terminal cysteine","volume":"278","author":"Qiu","year":"2003","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1509","article-title":"Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells","volume":"9","author":"Zhang","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500040045034","article-title":"Smoking and risk of graves' disease","volume":"269","author":"Prummel","year":"1993","journal-title":"JAMA"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1055-4","article-title":"Biotherapeutics for the treatment of multiple sclerosis: Hopes and hazards","author":"Warnke","year":"2013","journal-title":"J Neural Transm"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.6217550","article-title":"Multiple sclerosis: Distribution of T cell subsets within active chronic lesions","volume":"219","author":"Traugott","year":"1983","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190610","article-title":"Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions","volume":"19","author":"Hauser","year":"1986","journal-title":"Ann Neurol"},{"key":"B90","article-title":"Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis","volume":"38","author":"Prineas","year":"1978","journal-title":"Lab Invest"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: The T cell code to breach the blood-brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01133.x","article-title":"An autoimmunity odyssey: How autoreactive T cells infiltrate into the CNS","volume":"248","author":"Kawakami","year":"2012","journal-title":"Immunol Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1515\/bchm3.1994.375.7.447","article-title":"The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts","volume":"375","author":"Hurwitz","year":"1994","journal-title":"Biol Chem Hoppe Seyler"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J Med Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase\/ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1159\/000447806","article-title":"Acid sphingomyelinase (ASM) is a negative regulator of regulatory T cell (Treg) development","volume":"39","author":"Zhou","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600691","article-title":"Inhibition of acid sphingomyelinase allows for selective targeting of CD4+ conventional versus Foxp3+ regulatory T cells","volume":"197","author":"Hollmann","year":"2016","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83073","article-title":"Cell-intrinsic ceramides determine T cell function during melanoma progression","volume":"11","author":"Hose","year":"2022","journal-title":"Elife"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2017-0280","article-title":"The neutral sphingomyelinase 2 in T cell receptor signaling and polarity","volume":"399","author":"Collenburg","year":"2018","journal-title":"Biol Chem"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01007","article-title":"The activity of the neutral sphingomyelinase is important in T cell recruitment and directional migration","volume":"8","author":"Collenburg","year":"2017","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00217","article-title":"Neutral sphingomyelinase-2 (NSM 2) controls T cell metabolic homeostasis and reprogramming during activation","volume":"7","author":"De Lira","year":"2020","journal-title":"Front Mol Biosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1170884\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:42:33Z","timestamp":1680586953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1170884\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":101,"alternative-id":["10.3389\/fendo.2023.1170884"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1170884","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"article-number":"1170884"}}